Brain Maturation in Children With Localization Related Epilepsy (DYNAMAT)

December 20, 2018 updated by: Hospices Civils de Lyon

Dynamic Regional Brain Maturation in Children With Localization Related Epilepsy

This project intends to investigate children with idiopathic and cryptogenic localization related epilepsies, using a longitudinal assessment of structural and functional MRI data, in relation to neuropsychological evaluation. The rationale is primarily based on: 1) the frequent observation of selective cognitive dysfunctions in such children, the pathophysiology of which remains largely uncertain; 2) the recent major advances in the MRI investigation of brain maturation showing striking age and region dependant patterns.

The primary hypothesis is that some children with localization related epilepsies suffer from altered maturation in the epileptic brain regions, and that this abnormal maturation affects their cognitive abilities. 100 children with localization related epilepsies and 100 matched controls will be prospectively enrolled during the first two years of the disease (for patients) and benefit from a comprehensive phenotypic and neuropsychological evaluation once a year for 5 years. The brain maturation of these children will be longitudinally assessed using structural and functional MRI, and correlated with neuropsychological data. Investigators hope to demonstrate that children with localization related epilepsies and cognitive dysfunctions suffer from an abnormal brain maturation in regions underlying the epileptic activity and the altered cognitive processes. The finding could partly bridge the gap between these two abnormalities and help better understand their interaction and respective dynamic. Once validated, the study of regional brain maturation in children with epilepsy might be further used as a reliable surrogate marker or predictor of associated cognitive dysfunction.

Study Overview

Study Type

Interventional

Enrollment (Actual)

101

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bron, France, 69677
        • Hôpital Femme-Mère-Enfant, 59 Boulevard Pinel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 16 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • motivation to participate in the study for 5 years
  • for patients - one of the following diagnostics - BCECTS (benign childhood epilepsy with centro-temporal spikes), focal cryptogenic epilepsy of childhood, Panayiotopoulos syndrome, diagnosis established according to the current diagnostic criteria (ILAE, 1989)
  • for patients - no anti-epileptic drug for 24 months
  • normal MRI if available before inclusion
  • signed consent by on of the parents

Exclusion Criteria:

  • associated neurological and psychiatric diseases
  • other epileptic syndromes
  • other chronic severe disease
  • contra-indication for performing an MRI examination
  • claustrophobia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with BCECTS
Patients with BCECTS on which MRI, fMRI and neuropsychological assessment will be performed

Patients are investigated with the following sequences:

  • High-resolution 3D T1-weighted anatomical MRI.
  • DTI with 48 directions (to examine white matter)

fMRI investigations will be focused on :

  • language: investigation on possible atypical language networks in children with epilepsy. The fMRI task is a silent verb generation.
  • Social cognition: investigations on social cognition skills
  • Memory :
  • Declarative memory: investigations on the pattern of activations in the brain associated with successful memory formation and changes from childhood to adolescence
  • Working memory: A verbal and a spatial working memory task has been chosen, and is an adaptation of two published cross-sectional studies of working memory from Gabrieli and Sowell groups.
Patients undergo a repeated annual neuropsychological assessment over the five years of their participation in the project.
Other: Healthy volunteers
Healthy volunteers on which MRI, fMRI and neuropsychological assessment will be performed

Patients are investigated with the following sequences:

  • High-resolution 3D T1-weighted anatomical MRI.
  • DTI with 48 directions (to examine white matter)

fMRI investigations will be focused on :

  • language: investigation on possible atypical language networks in children with epilepsy. The fMRI task is a silent verb generation.
  • Social cognition: investigations on social cognition skills
  • Memory :
  • Declarative memory: investigations on the pattern of activations in the brain associated with successful memory formation and changes from childhood to adolescence
  • Working memory: A verbal and a spatial working memory task has been chosen, and is an adaptation of two published cross-sectional studies of working memory from Gabrieli and Sowell groups.
Patients undergo a repeated annual neuropsychological assessment over the five years of their participation in the project.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of grey/white matter volume
Time Frame: At 5 years
The aim is to evaluate structural brain maturation. All subjects will benefit from a 3D-T1 1,5 Tesla MRI and 48-directions Diffusion Tensor Imaging (DTI). We will calculate parametric maps of individual regional changes of grey/white matter fractions over time. This study aims to detect a significant difference in the rate of grey/white matter volume change over the epileptic region. We will further correlate a number of neuropsychological and clinical variables with the parametric maps of brain maturation. There will be annual measures up to 5 years after inclusion.
At 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in fMRI activation of language areas in brain during cognitive tasks
Time Frame: At 5 years
The aim is to evaluate functional brain maturation of language. All subjects will benefit from the functional MRI (fMRI) evaluation of the cognitive tasks. Changes in fMRI activation over time will be studied at the group level, taking into account all potentially relevant variables. This outcomme will be assessed at year 1, 3 and 5 after inclusion.
At 5 years
Changes in fMRI activation of social cognition areas in brain during cognitive tasks
Time Frame: At 5 years
The aim is to evaluate functional Brain Maturation of social cognition. All subjects will benefit from the functional MRI (fMRI) evaluation of the cognitive tasks. Changes in fMRI activation over time will be studied at the group level, taking into account all potentially relevant variables. This outcomme will be assessed at year 1, 3 and 5 after inclusion.
At 5 years
Changes in fMRI activation of Working memory areas in brain during cognitive tasks
Time Frame: At 5 years
The aim is to evaluate Functional Brain Maturation of Working memory. All subjects will benefit from the functional MRI (fMRI) evaluation of the cognitive tasks. Changes in fMRI activation over time will be studied at the group level, taking into account all potentially relevant variables. This outcomme will be assessed at year 1, 3 and 5 after inclusion.
At 5 years
Changes in fMRI activation of declarative memory areas in brain during cognitive tasks
Time Frame: At 5 years
The aim is to evaluate Functional Brain Maturation of declarative memory. All subjects will benefit from the functional MRI (fMRI) evaluation of the cognitive tasks. Changes in fMRI activation over time will be studied at the group level, taking into account all potentially relevant variables. This outcomme will be assessed at year 1, 3 and 5 after inclusion.
At 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sylvain RHEIMS, Service d'épileptologie fonctionnelle, Hôpital Pierre Wertheimer, Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2008

Primary Completion (Actual)

December 7, 2018

Study Completion (Actual)

December 7, 2018

Study Registration Dates

First Submitted

December 2, 2015

First Submitted That Met QC Criteria

January 6, 2016

First Posted (Estimate)

January 7, 2016

Study Record Updates

Last Update Posted (Actual)

December 21, 2018

Last Update Submitted That Met QC Criteria

December 20, 2018

Last Verified

December 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Benign Childhood Epilepsy With Centro-temporal Spikes (BCECTS)

Clinical Trials on MRI

3
Subscribe